NL-OMON22854已完成不适用
A randomized phase III study comparing induction chemotherapy to daily low dose Cisplatin both combined with high dose radiotherapy in patients with inoperable non-small cell lung cancer stage I, II and III.
/A0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Pathologically confirmed Non-small cell lung cancer;
- •2. Medically inoperable or irresectable NSCLC T 1-4, N0-3, M0;
排除标准
- •1. Previous chemotherapy and/or radiotherapy of the chest;
- •2. Superior Vena cava syndrome;
研究者
相似试验
已完成
不适用
A randomised phase III study comparing induction chemotherapy to daily low dose Cisplatin both combined with high dose radiotherapy in patients with inoperable non-small cell lung cancer stage I, II and IIIung cancerMalignant neoplasm of bronchus or lungCancerISRCTN73271276etherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NKI/AVL) and Academic Medical Centre (AMC) (Netherlands)100
已完成
不适用
A randomized phase III study on the effect of the chimeric anti-CD20 monoclonal antibody (MabThera) during sequential chemotherapy followed by autologous stem cell transplantation in patients with relapsed or progressive B-cell non-Hodgkin’s lymphoma.on Hodgkin’s LymphomaNL-OMON29096Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Daniel den HoedPostbus 52013008 AE RotterdamTel: 010 4391568Fax: 010 4391028e-mail: hdc@erasmusmc.nl300
已完成
不适用
Randomized induction and post induction therapy in older patients (>= 61 yrs of age) with acute myelocytic leukemia (AML) and refractory anemia with excess of blasts (RAEB, RAEB-t).Acute myelocytic leukemia, RAEB, RAEB-t.NL-OMON21122Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON)P/a HOVON Data CenterErasmus MC - DanielPostbus 5201NL-3008 AE RotterdamTel: 010 4391568Fax: 010 4391028e-mail: hdc@erasmusmc.nl800
Unknown
3 期
Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLCSCLCNCT02990780Shanghai Chest Hospital266
进行中（未招募）
1 期
A Randomized Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients up to 65 Years of Age (IFM/DFCI 2009) - IFM/DFCI 2009EUCTR2009-016871-32-FRCHU de TOULOUSE1,000